新一代测序重新定义了三阴性骨髓增殖性肿瘤的诊断。 - Suppr | 超能文献

Next-generation sequencing redefines the diagnosis of triple-negative myeloproliferative neoplasms.

作者信息

Wu Sanyun, Luo Ping, Yu Yalan, Xiong Bei, Wang Yingying, Zuo Xuelan

机构信息

Department of Hematology, Zhongnan Hospital of Wuhan University, Donghu Road, No. 169, Wuhan, China.

出版信息

Ann Hematol. 2022 Mar;101(3):705-708. doi: 10.1007/s00277-021-04561-5. Epub 2021 Sep 13.

DOI:10.1007/s00277-021-04561-5

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Next-generation sequencing redefines the diagnosis of triple-negative myeloproliferative neoplasms.新一代测序重新定义了三阴性骨髓增殖性肿瘤的诊断。

Ann Hematol. 2022 Mar;101(3):705-708. doi: 10.1007/s00277-021-04561-5. Epub 2021 Sep 13.

2

Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations.伴有钙网蛋白突变的骨髓增殖性肿瘤的独特临床特征。

Haematologica. 2014 Jul;99(7):1184-90. doi: 10.3324/haematol.2014.107482. Epub 2014 Jun 3.

3

[Complex molecular genetic algorithm in the diagnosis of myeloproliferative neoplasms].[复杂分子遗传算法在骨髓增殖性肿瘤诊断中的应用]

Orv Hetil. 2014 Dec 28;155(52):2074-81. doi: 10.1556/OH.2014.30051.

4

The diagnosis and management of polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the JAK2 V617F era.JAK2 V617F时代真性红细胞增多症、原发性血小板增多症和原发性骨髓纤维化的诊断与管理

Clin Adv Hematol Oncol. 2009 May;7(5):334-42.

5

Molecular classification of myeloproliferative neoplasms-pros and cons.骨髓增殖性肿瘤的分子分类：利弊。

Curr Hematol Malig Rep. 2013 Dec;8(4):342-50. doi: 10.1007/s11899-013-0179-9.

6

Different expression patterns of LGALS1 and LGALS3 in polycythemia vera, essential thrombocythemia and primary myelofibrosis.LGALS1和LGALS3在真性红细胞增多症、原发性血小板增多症和原发性骨髓纤维化中的不同表达模式。

J Clin Pathol. 2016 Oct;69(10):926-9. doi: 10.1136/jclinpath-2016-203948. Epub 2016 Jul 11.

7

Searching for CALRity in myeloproliferative neoplasms.在骨髓增殖性肿瘤中探寻CALR的真相。

Am J Clin Pathol. 2015 May;143(5):617-9. doi: 10.1309/AJCPZFWDM4GDTCI8.

8

Quantification of JAK2V617F mutation by next-generation sequencing technology.采用新一代测序技术对JAK2V617F突变进行定量分析。

Am J Hematol. 2013 Jun;88(6):536-7. doi: 10.1002/ajh.23446. Epub 2013 May 13.

9

Molecular and genetic bases of myeloproliferative disorders: questions and perspectives.骨髓增殖性疾病的分子和遗传基础：问题与展望

Clin Lymphoma Myeloma. 2009;9 Suppl 3:S329-39. doi: 10.3816/CLM.2009.s.032.

10

Myeloproliferative neoplasms.骨髓增殖性肿瘤。

Clin Med (Lond). 2013 Apr;13(2):188-92. doi: 10.7861/clinmedicine.13-2-188.

引用本文的文献

1

Detection and quantification of JAK2V617F copy number by droplet digital PCR versus real-time PCR.采用液滴数字 PCR 与实时 PCR 检测和定量 JAK2V617F 拷贝数。

Ann Hematol. 2024 Feb;103(2):421-426. doi: 10.1007/s00277-023-05544-4. Epub 2023 Nov 16.

2

-negative myeloproliferative neoplasms in the era of next-generation sequencing.下一代测序时代的阴性骨髓增殖性肿瘤

Front Genet. 2023 Sep 8;14:1241912. doi: 10.3389/fgene.2023.1241912. eCollection 2023.